UroGen Pharma
URGN
$9.39
Share price
-7.03%
Change (1 day)
-27.49%
Change (1 year)
Categories
Revenue for UroGen Pharma (URGN)
Revenue in 2024 (TTM): $90.39 Million USD
According to UroGen Pharma's latest financial reports the company's current revenue (TTM 
) is $90.39 Million USD. an increase over the revenue in the year 2023 that were of $82.71 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for UroGen Pharma from 2017 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | $90.39 M | 9.29% |
| 2023 | $82.71 M | 28.52% |
| 2022 | $64.35 M | 33.96% |
| 2021 | $48.04 M | 307.17% |
| 2020 | $11.79 M | 65450% |
| 2019 | $0.01 M | -98.4% |
| 2018 | $1.12 M | -86.17% |
| 2017 | $8.15 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |